Brent Ogilvie

S 1 Ltd. produces powdered and liquid sleep-enhancing milk. The company is based in Auckland, New Zealand.

Breathe Easy Ltd. develops drug for cystic fibrosis. It is developing an inhaled medicine called Citramel, as a core therapy to improve lung function and to potentially enhance the effectiveness of other inhaled CF therapies such as antibiotics. The company was founded on April 30, 2009 by Brent Stuart Ogilvie, Robert bartlett Elliott and Andrea Miller and is headquartered in Auckland, New Zealand.

Pacific Channel Ltd (Pacific Channel) is a venture capital firm founded in 2006 by Brent S. Ogilvie. The firm is headquartered in Auckland, New Zealand.

SciTOX Ltd. manufactures and promotes market-specific toxicology analyzers. Its products include alpha, it is technology for the measurement of toxicity in wastewater treatment plants and from their waste-contributing customers, and uniTox is a single-sample analyzer for developing research applications in electrochemistry and toxicity measurement. The company was founded by RJohn Denholm Patterson and Ralph Henry Wattinger in 2008 and is headquartered in Christchurch, New Zealand.

Footfalls & Heartbeats (UK) Ltd. designs, develops, and manufactures smart textiles. The firm uses nano-scale interactions within the textile to make the fabric itself the sensor, avoiding the need for wires or miniature electronics. The company was founded by Simon McMaster in 2010 and is headquartered in Nottingham, the United Kingdom.

Living Green Group Ltd. focuses on making products that enable people to live a better life. Its brands are iCleans, PetsLove, Sigrids Baby and Kids, Sigrids Specialty Cleaners, Econogreen, and Homewood. The company was founded by Nigel Haig McLisky and Sigrid Alice Sylvia McLisky on March 1, 2011 and is headquartered in Auckland, New Zealand.

Engender Technologies Ltd. engages in the research and development of gender selection especially in the dairy industry. The company was founded by Miriam Cather Simpson on October 6, 2011 and is headquartered in Auckland, New Zealand.

Pheromite Ltd. develops treatment for Varroa destructor. It provides a rational compound discovery process in which potential compounds are screened to determine if they can affect the receptor. The company was founded by Pablo German in January, 2016 and is headquartered in Grafton, New Zealand.